Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

August 14, 2025 08:15 ET | Source: Nuwellis, Inc.

Nuwellis, Inc. Reports Second Quarter 2025 Financial Results and Business Highlights

MINNEAPOLIS, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a commercial-stage medical technology company dedicated to transforming care for fluid overload patients, today...
August 07, 2025 08:15 ET | Source: Nuwellis, Inc.

Nuwellis to Exit International Operations to Accelerate U.S. Revenue Growth and Strategic Focus

Nuwellis to Exit International Operations to Accelerate U.S. Revenue Growth and Strategic Focus
August 06, 2025 08:15 ET | Source: Nuwellis, Inc.

Nuwellis Postpones Second Quarter 2025 Earnings Release and Conference Call to August 14, 2025

Nuwellis Q2 Earnings Call Postponement
August 05, 2025 08:15 ET | Source: Nuwellis, Inc.

Nuwellis Announces the First Successful Outpatient Application of the Aquadex Smartflow® System Under New CMS Code

NUWELLIS ANNOUNCES THE FIRST SUCCESSFUL OUTPATIENT APPLICATION OF THE AQUADEX SMARTFLOW® SYSTEM UNDER NEW CMS CODE
August 04, 2025 17:24 ET | Source: Nuwellis, Inc.

Nuwellis Stockholders Approve All Proposals at Special Meeting

Nuwellis Stockholders Approve All Proposals at Special Meeting
July 23, 2025 08:45 ET | Source: Nuwellis, Inc.

Nuwellis Participates in the Virtual Investor “What’s Your Story” Summer Spotlight On-Demand Conference

John Erb, President and CEO of Nuwellis, participated in the Virtual Investor “What’s Your Story” Summer Spotlight On-Demand Conference.
July 23, 2025 08:15 ET | Source: Nuwellis, Inc.

Nuwellis Regains Compliance with Nasdaq Listing Requirements

Nuwellis Regains Compliance with Nasdaq Listing Requirements
July 22, 2025 08:15 ET | Source: Nuwellis, Inc.

Nuwellis, Inc. To Report Second Quarter 2025 Financial Results on August 12, 2025

Nuwellis Announces Q2 Earnings Advisory
July 17, 2025 07:35 ET | Source: Nuwellis, Inc.

Nuwellis Announces Termination of REVERSE-HF Clinical Trial to Focus on Strategic Growth in Outpatient Heart Failure Care

Nuwellis Announces Termination of REVERSE-HF Clinical Trial
July 15, 2025 16:05 ET | Source: Nuwellis, Inc.

Nuwellis Secures New U.S. Patent, Strengthening Its Position as a Leader in Fluid Management Innovation

Nuwellis Secures New U.S. Patent

keyboard_arrow_left Previous Page

Next Page keyboard_arrow_right